Business
The Power Play by The Market Herald Releases New Interviews with Avrupa Minerals, good natured Products, Hank Payments, Psyence Group, and Empower Clinics
VANCOUVER, BC / ACCESSWIRE / June 2, 2022 / The Power Play by The Market Herald has announce...
About this update from Futr Corporation
[{"type":"text","content":"The Power Play by The Market Herald Releases New Interviews with Avrupa Minerals, good natured Products, Hank Payments, Psyence Group, and Empower ClinicsVANCOUVER, BC / ACCESSWIRE / June 2, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Avrupa Minerals, good natured Products, Hank Payments, Psyence Group, and Empower Clinics on their latest news.The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.Avrupa Minerals (TSXV:AVU) receives exploration permit for the Slivova gold projectAvrupa Minerals (AVU) has received a 7-year exploration permit covering the Slivova gold prospect in Kosovo. The company discovered the gold prospect in 2012. Avrupa Minerals CEO and Director Paul Kuhn sat down with Coreena Robertson to discuss the news.For the full interview with Paul Kuhn and to learn more about Avrupa Minerals, click heregood natured Products (TSXV:GDNP) reports Q1 resultsgood natured Products (GDNP) announced its financial results for the three months ended March 31, 2022. The company its second consecutive quarter of positive adjusted EBITDA. CEO Paul Antoniadis sat down with Coreena Robertson to discuss the results.For the full interview with Paul Antoniadis and to learn more about good natured Products, click hereHank Payments (TSXV:HANK) and Fair Fintech announce strategic partnershipHank Payments (HANK) has signed a partnership agreement with Fair Fintech Inc. Under the partnership, Hank and Fair will offer the Fair banking products to Hank consumers. CEO Michael Hilmer sat down with Coreena Robertson to discuss the partnership.For the full interview with Michael Hilmer and to learn more about Hank Payments, click herePsyence Group (CSE:PSYG) provides corporate updatePsyence Group (PSYG) has provided an update on its three strategic focus areas namely: Psyence Therapeutics, Psyence Production and Psyence Function. Dr. Clive Ward-Able has been appointed as Medical Director, Head of Research & Development and Early Commercialization for Psyence. Psyence CEO Dr. Neil Maresky, sat down with Coreena Robertson to discuss the update.For the full interview with Neil Maresky and to learn more about Psyence Group, click hereEmpower Cli...